Beneficence and nonmaleficence are two foundational principles in medical ethics. Beneficence is the obligation to act in ways that promote a patient’s well-being. Nonmaleficence is the obligation to avoid causing harm. Together, they form half of the four-principle framework that guides ethical decision-making in healthcare, alongside autonomy (respecting a patient’s right to choose) and justice (distributing care fairly).
Beneficence: The Duty to Do Good
Beneficence goes beyond simply being kind. In a medical context, it is a formal obligation, not an optional act of charity. The 1979 Belmont Report, a landmark U.S. government document on research ethics, defined it with two complementary rules: do not harm, and maximize possible benefits while minimizing possible harms. That framing treats helping people as something healthcare providers and researchers owe to patients, not something they earn extra credit for.
In everyday clinical care, beneficence looks like a nurse administering pain medication to relieve suffering, a provider making a referral to a specialist when a problem falls outside their expertise, or a care team accommodating a patient’s cultural or dietary needs. It also includes less obvious actions: listening to a patient’s concerns, adjusting their positioning for comfort, or ensuring they can communicate with someone fluent in their preferred language. The through-line is actively working to improve someone’s situation, not just avoiding making it worse.
Beneficence also operates at a societal level. When researchers conduct clinical trials, they are obligated to give forethought to maximizing benefits and reducing risks for participants. But the broader community also has a stake: the knowledge gained from research can lead to better treatments for future patients. The principle asks that both the immediate risks to study participants and the long-term potential gains for society be weighed honestly.
Nonmaleficence: The Duty to Avoid Harm
Nonmaleficence is often summarized by the Latin phrase “primum non nocere,” or “first, do no harm.” It is the obligation of a healthcare provider not to cause unnecessary suffering, injury, or loss. The principle supports several specific moral rules: do not kill, do not cause pain or suffering, do not incapacitate, do not cause offense, and do not deprive others of the goods of life.
In practice, nonmaleficence means weighing the burdens of every intervention against its benefits and avoiding treatments that are inappropriately burdensome. A surgeon choosing not to operate on a frail patient when the risks clearly outweigh the potential gains is acting on nonmaleficence. So is a physician who stops a medication because its side effects are causing more suffering than the condition it treats. The principle also applies to decisions about what not to do: withholding a treatment that would only prolong dying without improving quality of life, for example, can be an act of nonmaleficence rather than neglect.
How the Two Principles Differ
The distinction is subtle but important. Nonmaleficence sets a floor: at minimum, don’t make things worse. Beneficence raises the ceiling: actively try to make things better. A provider who avoids prescribing a drug with dangerous side effects is practicing nonmaleficence. A provider who takes extra time to find an alternative treatment that improves the patient’s quality of life is practicing beneficence. One principle restrains action, the other compels it.
Some ethical frameworks, including the Belmont Report, fold nonmaleficence into beneficence as two sides of the same coin. The four-principle framework developed by ethicists Tom Beauchamp and James Childress, which is widely used in medical training, treats them as separate principles. Either way, the core idea is the same: healthcare decisions should be guided by both the active pursuit of good outcomes and the vigilant avoidance of harm.
When Beneficence and Nonmaleficence Conflict
These two principles frequently pull in opposite directions, and that tension is at the heart of many difficult medical decisions. Nearly every effective treatment carries some risk of harm. Chemotherapy kills cancer cells but also damages healthy tissue. Surgery can save a life but carries the risk of infection, complications, or death. The ethical question is always whether the expected benefit justifies the expected harm.
End-of-life care brings this conflict into sharp focus. Beneficence in palliative care emphasizes relieving symptoms that impair quality of life, while nonmaleficence emphasizes stopping interventions that may actually be causing harm. Consider a patient in an intensive care unit whose organs are failing despite aggressive treatment. An intensivist may recommend discontinuing mechanical ventilation and medications that maintain blood pressure because continuing them is futile. The goal shifts from prolonging life (beneficence in one sense) to preventing unnecessary suffering (nonmaleficence). Both principles are in play, but they point toward different actions depending on the circumstances.
Decisions about cardiopulmonary resuscitation, artificial nutrition and hydration, and sedation at the end of life all require balancing these principles. In palliative care, beneficence and nonmaleficence are considered the most central ethical principles, and applying them thoughtfully is essential to achieving a comfortable end-of-life period for patients.
The Role of Risk-Benefit Analysis
The practical tool for balancing beneficence and nonmaleficence is risk-benefit analysis. Every medical decision, from prescribing an antibiotic to approving a new medical device, involves assessing whether the likely benefits outweigh the likely harms. The FDA, for instance, evaluates medical devices by weighing patient perspectives on what constitutes meaningful benefit, what constitutes acceptable risk, and what alternatives exist. If a device helps patients but carries a known risk, the question becomes whether that tradeoff is reasonable given the available options.
This same logic applies at the bedside. A physician recommending surgery will consider the probability of success, the severity of potential complications, the patient’s overall health, and what happens if the patient chooses not to have the procedure. The goal is not to eliminate all risk, which is impossible, but to ensure that the potential for benefit clearly justifies the potential for harm.
Beneficence, Paternalism, and Patient Choice
One complication with beneficence is that it can slide into paternalism, where a provider decides what is “best” for a patient without fully considering the patient’s own preferences. A doctor might believe a particular treatment is clearly in a patient’s interest, but the patient may disagree based on their values, beliefs, or life circumstances. This is where the principle of autonomy acts as a check on beneficence. Doing good for someone still requires respecting their right to define what “good” means for them.
Modern medical ethics treats these principles as a set, not a hierarchy. No single principle automatically overrides the others. Instead, providers are expected to weigh all four, autonomy, beneficence, nonmaleficence, and justice, when facing an ethical decision. The framework doesn’t produce easy answers, but it provides a structured way to think through situations where the right course of action is genuinely unclear.
Applications Beyond the Bedside
These principles are increasingly relevant in areas like artificial intelligence in healthcare. AI algorithms used to assist in diagnosis or treatment recommendations must be carefully designed and validated to ensure they produce accurate results and don’t mislead clinicians. When an algorithm is trained on biased or incomplete data, it can perpetuate existing inequities in healthcare, causing harm to the very populations it is meant to serve. Nonmaleficence, in this context, means rigorously testing AI tools before they influence patient care. Beneficence means using those tools to genuinely improve outcomes, not just to increase efficiency.
Research ethics also depends heavily on both principles. Investigators running clinical trials are obligated to minimize risk to participants and to justify their studies on the basis of a favorable risk-benefit assessment. The requirement for informed consent, where participants understand the potential risks before agreeing to take part, is rooted in these same obligations.